Obesity and Kidney Disease: Hidden Consequences of the Epidemic

Overview

Journal Can J Kidney Health Dis

Publisher Sage Publications

Date 2017 May 26

PMID 28540059

Citations 71

Authors

Csaba P Kovesdy

Susan L Furth

Carmine Zoccali

Affiliations

Soon will be listed here.

Abstract

Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for the risk of diabetes, cardiovascular disease, and also for chronic kidney disease (CKD). A high body mass index is one of the strongest risk factors for new-onset CKD. In individuals affected by obesity, a compensatory hyperfiltration occurs to meet the heightened metabolic demands of the increased body weight. The increase in intraglomerular pressure can damage the kidneys and raise the risk of developing CKD in the long term. The incidence of obesity-related glomerulopathy has increased 10-fold in recent years. Obesity has also been shown to be a risk factor for nephrolithiasis, and for a number of malignancies including kidney cancer. This year the World Kidney Day promotes education on the harmful consequences of obesity and its association with kidney disease, advocating healthy lifestyle and health policy measures that make preventive behaviors an affordable option.

Citing Articles

Obesity as a Risk Factor for Hyperglycemia, Electrolyte Disturbances, and Acute Kidney Injury in the Emergency Department.

Crintea I, Cindrea A, Mederle O, Fulga T, Marza A, Petrica A Biomedicines. 2025; 13(2).

PMID: 40002762 PMC: 11853456. DOI: 10.3390/biomedicines13020349.

Development of Chronic Kidney Disease Screening Integrative Care Model Led by Community Pharmacists.

Srimongkhol P, Anutrakulchai S, Theeranut A, Methakanjanasak N, Lertsinudom S Pharmacy (Basel). 2025; 13(1).

PMID: 39998025 PMC: 11858870. DOI: 10.3390/pharmacy13010027.

Regional autozygosity association with albumin-to-creatinine ratio reveals a novel FTO region in an Indigenous Australian population.

Arunachalam V, Tran K, Hoy W, Lea R, Nagaraj S Eur J Hum Genet. 2025; .

PMID: 39994404 DOI: 10.1038/s41431-025-01799-9.

Exploring Opportunities to Better Characterize the Effects of Dietary Protein on Health across the Lifespan.

Carbone J, Phillips S, Weaver C, Hughes J, Pasiakos S Adv Nutr. 2024; 16(1):100347.

PMID: 39608572 PMC: 11699594. DOI: 10.1016/j.advnut.2024.100347.

Utility of shear wave elastography in evaluation of children with chronic kidney disease.

Tiwari K, Mittal A, Sureka B, Narayanan D, Nalwa A, Vishwajeet V Pediatr Nephrol. 2024; .

PMID: 39556210 DOI: 10.1007/s00467-024-06573-5.

References

Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S . Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004; 65(5):1870-6. DOI: 10.1111/j.1523-1755.2004.00582.x. View

Kalantar-Zadeh K, Kuwae N, Wu D, Shantouf R, Fouque D, Anker S . Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr. 2006; 83(2):202-10. DOI: 10.1093/ajcn/83.2.202. View

Ruster C, Wolf G . The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Semin Nephrol. 2013; 33(1):44-53. DOI: 10.1016/j.semnephrol.2012.12.002. View

Foster M, Hwang S, Massaro J, Hoffmann U, deBoer I, Robins S . Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study. Obesity (Silver Spring). 2010; 19(6):1284-9. PMC: 3096746. DOI: 10.1038/oby.2010.308. View

Vivante A, Golan E, Tzur D, Leiba A, Tirosh A, Skorecki K . Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med. 2012; 172(21):1644-50. PMC: 4941233. DOI: 10.1001/2013.jamainternmed.85. View

Scales Jr C, Smith A, Hanley J, Saigal C . Prevalence of kidney stones in the United States. Eur Urol. 2012; 62(1):160-5. PMC: 3362665. DOI: 10.1016/j.eururo.2012.03.052. View

Wing R, Bolin P, Brancati F, Bray G, Clark J, Coday M . Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013; 369(2):145-54. PMC: 3791615. DOI: 10.1056/NEJMoa1212914. View

Grivennikov S, Greten F, Karin M . Immunity, inflammation, and cancer. Cell. 2010; 140(6):883-99. PMC: 2866629. DOI: 10.1016/j.cell.2010.01.025. View

Rauchhaus M, Coats A, Anker S . The endotoxin-lipoprotein hypothesis. Lancet. 2000; 356(9233):930-3. DOI: 10.1016/S0140-6736(00)02690-8. View

10.

Lu J, Molnar M, Naseer A, Mikkelsen M, Kalantar-Zadeh K, Kovesdy C . Association of age and BMI with kidney function and mortality: a cohort study. Lancet Diabetes Endocrinol. 2015; 3(9):704-14. PMC: 4547884. DOI: 10.1016/S2213-8587(15)00128-X. View

11.

Subramanian S, Perkins J, Ozaltin E, Davey Smith G . Weight of nations: a socioeconomic analysis of women in low- to middle-income countries. Am J Clin Nutr. 2010; 93(2):413-21. PMC: 3021433. DOI: 10.3945/ajcn.110.004820. View

12.

Chobanian M, Hammerman M . Insulin stimulates ammoniagenesis in canine renal proximal tubular segments. Am J Physiol. 1987; 253(6 Pt 2):F1171-7. DOI: 10.1152/ajprenal.1987.253.6.F1171. View

13.

Sharma K . The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int. 2009; 76(2):145-8. DOI: 10.1038/ki.2009.137. View

14.

Postorino M, Marino C, Tripepi G, Zoccali C . Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol. 2009; 53(15):1265-72. DOI: 10.1016/j.jacc.2008.12.040. View

15.

de Vries A, Ruggenenti P, Ruan X, Praga M, Cruzado J, Bajema I . Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014; 2(5):417-26. DOI: 10.1016/S2213-8587(14)70065-8. View

16.

Cattaneo A, Monasta L, Stamatakis E, Lioret S, Castetbon K, Frenken F . Overweight and obesity in infants and pre-school children in the European Union: a review of existing data. Obes Rev. 2009; 11(5):389-98. DOI: 10.1111/j.1467-789X.2009.00639.x. View

17.

Klisic J, Hu M, Nief V, Reyes L, Fuster D, Moe O . Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence. Am J Physiol Renal Physiol. 2002; 283(3):F532-9. DOI: 10.1152/ajprenal.00365.2001. View

18.

Ribstein J, du Cailar G, Mimran A . Combined renal effects of overweight and hypertension. Hypertension. 1995; 26(4):610-5. DOI: 10.1161/01.hyp.26.4.610. View

19.

Bhaskaran K, Douglas I, Forbes H, Dos-Santos-Silva I, Leon D, Smeeth L . Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014; 384(9945):755-65. PMC: 4151483. DOI: 10.1016/S0140-6736(14)60892-8. View

20.

Taylor E, Stampfer M, Curhan G . Obesity, weight gain, and the risk of kidney stones. JAMA. 2005; 293(4):455-62. DOI: 10.1001/jama.293.4.455. View